GlassScriptPhysician profile
Danielle A Shiller
NPI 1841212982
$221,478.36
in general payments reported to CMS, 2019-2025
32 companies · $75.85 in 2025
The $75.85 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160K · 2020: $38K · 2021: $23K · 2025: $75.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $75.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $75.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $204,098.82 | 2019-2021 | |
| Meditrina | $6,340.86 | 2020-2021 | |
| Duchesnay USA Incorporated | $6,231.64 | 2019 | |
| Acessa Health INC. | $3,384.79 | 2019-2020 | |
| Amgen INC. | $301.02 | 2019-2021 | |
| Novo Nordisk INC | $208.67 | 2019-2020 | |
| Therapeuticsmd, INC. | $108.46 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $106.19 | 2021 | |
| Amarin Pharma, INC. | $95.79 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $95.64 | 2020-2021 | |
| Regeneron Pharmaceuticals, INC. | $75.85 | 2025 | |
| Millicent US INC | $70.48 | 2019-2021 | |
| Astellas Pharma US INC | $46.20 | 2019 | |
| Allergan, INC. | $45.25 | 2019-2020 | |
| Eisai INC. | $38.07 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $28.88 | 2019-2020 | |
| Lupin INC. | $19.95 | 2019 | |
| Glaxosmithkline, LLC. | $18.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.72 | 2021 | |
| Agile Therapeutics, INC. | $17.38 | 2021 | |
| Ironwood Pharmaceuticals, INC | $17.32 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.99 | 2020 | |
| Exeltis, USA INC. | $15.57 | 2021 | |
| Genzyme Corporation | $14.93 | 2021 | |
| Smith+Nephew, INC. | $13.14 | 2019 | |
| Evofem Biosciences, INC. | $12.98 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.95 | 2020 | |
| Avion Pharmaceuticals | $11.57 | 2021 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Shiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.